Titlebook: ;

名次后綴

Foolproof

過(guò)渡時(shí)期

暫時(shí)過(guò)來(lái)

免費(fèi)

,Treatment of Hyperthyroidism in Patients with Graves’ Orbitopathy, pathogenetic mechanisms of the disease. Graves’ orbitopathy (GO), the most frequent extrathyroidal manifestation of Graves’ disease, is present in about 25 % of newly diagnosed Graves’ patients, and rarely progresses over time. Neither ATDs nor thyroidectomy appear to affect the natural course of G

流動(dòng)性

,Assessment and Management Plan for Graves’ Orbitopathy, gradual onset of proptosis and lid retraction, usually associated with fat expansion on orbital imaging. In approximately one-third of cases, the disease develops rapidly with significant involvement of one or more extraocular muscles and resultant periocular soft tissue congestion, motility disrup

emulsify

過(guò)渡時(shí)期

Hyperalgesia

MAPLE

,Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy, disease development. Our group and others have further focused on thyroid-specific genes such as TSH receptor and thyroglobulin gene and have shown that they play a major role in GD. Genetic studies in GO, however, did not show consistent results. Since the entire risk for GD is not conveyed by gen